Press release
Role Of Rising Chronic Disease Incidence In Driving Growth Of The Narcotic Drug Market Driving Market Acceleration in the Narcotic Drugs Industry, 2025
Narcotic Drugs Market
How Large Will the Narcotic Drugs Market Size By 2025?
In recent times, there has been stable growth in the market size of narcotic drugs. An elevation from $14.26 billion in 2024 to $14.71 billion in 2025, amounting to a compound annual growth rate (CAGR) of 3.1%, is predicted. The significant growth during the historical phase can be credited to the mounting medical necessity, escalating public health apprehensions, enhanced access to healthcare, increasing instances of chronic pain, and government efforts to ameliorate pain management.
How Big Is the Narcotic Drugs Market Size Expected to Grow by 2029?
Anticipated expansion in the narcotic drugs market is projected to experience a steady rise in the upcoming years, increasing to ""$17.67 billion in 2029"" with a compound annual growth rate (CAGR) of 4.7%. This predicted growth over the forecasted period is owed to factors such as a surging demand for generic narcotic drugs, an escalating pharmaceutical industry, an increased interest in minimally invasive surgeries, and the growing usage of narcotic drugs in palliative care. The forthcoming period is also likely to witness trends such as innovation within the pharmaceutical industry, telemedicine and remote monitoring, the creation of non-opioid alternatives, and the application of artificial intelligence (AI) in the discovery and development of drugs.
View the full report here:
https://www.thebusinessresearchcompany.com/report/narcotic-drugs-global-market-report
Which Key Market Drivers Powering Narcotic Drugs Market Expansion and Growth?
The growth of the narcotic drug market is expected to be driven by the increasing prevalence of chronic diseases. Chronic illness extends for three months or more and can worsen over time. Narcotic drugs are administered to alleviate symptoms of chronic diseases such as cancer, chronic pain syndrome, terminal disease, and severe arthritis. For example, in June 2024, the National Health Service, a government department based in the UK, found that in 2023, over half a million (549,000) more individuals in England were at risk of developing type 2 diabetes, totaling the number of people with non-diabetic hyperglycemia, also known as pre-diabetes, registered with a GP to 3,615,330. This marks a substantial growth from 3,065,825 in 2022, indicating an increase of almost 20%. As such, the growing prevalence of chronic diseases is a key driver for the expansion of the narcotic drug market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12863&type=smp
What Are the Key Trends Driving Narcotic Drugs Market Growth?
In a bid to bolster their market standing, prominent firms in the narcotic drug sector are increasingly centering their operations on product development and innovation. This is aimed at offering dependable products to their clientele. A case in point is Indivior PLC, a pharmaceutical firm based in the US, which in May 2023, unveiled OPVEE (nalmefene) nasal spray. This is a life-saving medication used in cases of opioid overdoses from natural and synthetic opioids like fentanyl. It is advised for immediate use in confirmed or suspected cases of opioid overdoses in both adults and pediatric patients aged 12 years and above, as evidenced by respiratory and central nervous system depression.
What Are the Emerging Segments in the Narcotic Drugs Market?
The narcotic drugs market covered in this report is segmented -
1) By Drug: Opi*um, Her*oin, Codeine, Oxycodone, Other Drugs
2) By Source: Natural, Semi-Synthetic, Synthetic
3) By Indication: Pain Management, Cough, Diarrhea, Dysentery, Asthma, Other Indications
4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
5) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users
Subsegments:
1) By Op*ium: Raw Opi*um, Op*ium Extracts, Op*ium Derivatives
2) By Her*oin: Diacetylmorphine, Her*oin Hydrochloride, He*roin Acetate
3) By Codeine: Codeine Phosphate, Codeine Sulfate
4) By Oxycodone: Oxycodone Hydrochloride, Oxycodone Acetaminophen, Controlled-Release Oxycodone
5) By Other Drugs: Fentanyl, Morphine, Hydromorphone, Methadone, Buprenorphine
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12863&type=smp
Who Are the Global Leaders in the Narcotic Drugs Market?
Major companies operating in the narcotic drugs market are Pfizer Inc., Johnson and Johnson Limited, AbbVie Inc., Novartis AG, AstraZeneca PLC, Sanofi S.A., Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Ltd., Purdue Pharma LP, Hikma Pharmaceuticals PLC, Endo Pharmaceuticals Inc., Amneal Pharmaceuticals LLC, Lupin Ltd., Mallinckrodt Pharmaceuticals, Alvogen Inc., Indivior Inc., Impax Laboratories Inc., Collegium Pharmaceutical Inc., Lannett Co Inc., Par Pharmaceutical Inc., West-Ward Pharmaceuticals Corp.
Which are the Top Profitable Regional Markets for the Narcotic Drugs Industry?
Asia-Pacific was the largest region in the narcotic drugs market in 2024. The regions covered in the narcotic drug market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12863
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Role Of Rising Chronic Disease Incidence In Driving Growth Of The Narcotic Drug Market Driving Market Acceleration in the Narcotic Drugs Industry, 2025 here
News-ID: 4182374 • Views: …
More Releases from The Business research company
Low-Grade Glioma Market Research Reveals Strong 5.6% CAGR Outlook Through 2030
The low-grade glioma market is on the brink of significant expansion as advancements in treatment options and growing awareness about this condition continue to evolve. With cutting-edge research and increasing investments, the market is set to witness remarkable changes that will enhance patient care and outcomes. Let's explore the market size, key players, emerging trends, and segmentation details shaping the future of the low-grade glioma landscape.
Projected Growth and Market Size…
Low Molecular Weight Heparin Market Intelligence Report Covers Trends, Segments …
An Overview of the Low Molecular Weight Heparin Market Outlook
The low molecular weight heparin (LMWH) market is set to experience significant expansion over the coming years. Forecasts indicate the market will reach a valuation of $8.06 billion by 2030, growing at a compound annual growth rate (CAGR) of 8.6%. This upswing is largely driven by demographic shifts, such as an aging population, coupled with a rise in cardiovascular…
Longevity And Anti-senescence Therapy Market Trends Support A 6.2% CAGR Outlook …
The field of longevity and anti-senescence therapies is rapidly evolving as researchers and companies focus on extending healthy lifespan and combating age-related diseases. With breakthroughs in various therapeutic approaches and growing consumer interest in aging solutions, this market is set for substantial expansion in the coming years. Below, we explore the market's projected growth, key players, influential trends, and detailed segment analyses.
Projected Market Growth and Future Outlook for Longevity and…
Locally Advanced Pancreatic Cancer Market Report Examines Industry Trends, Growt …
The locally advanced pancreatic cancer market is positioned for significant expansion in the coming years, driven by advancements in treatment methods and growing research investments. Understanding the market's size, key players, and emerging trends provides valuable insight into how this challenging disease is being addressed on a global scale.
Forecasted Market Size and Growth Trajectory of the Locally Advanced Pancreatic Cancer Market
The market for locally advanced pancreatic cancer treatments…
More Releases for Pharma
Schizophrenia Market Gains Momentum with Expanding Pipeline and Investment Poten …
The Key Schizophrenia Companies in the market include - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Acadia Pharmaceuticals, Boehringer Ingelheim, Cerevel Therapeutics, AstraZeneca, Eli Lilly and Company, Karuna Therapeutics, Neurocrine Biosciences, and others.
DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2036" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed…
Schizophrenia Market: Expanding Revenue Landscape to 2034 - DelveInsight | Teva …
The Key Schizophrenia Companies in the market inlclude - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Reviva Pharmaceuticals, and others.
DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2034" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed insights into the disease, including historical and projected epidemiology, helping stakeholders understand the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
